Categories
Review Articles Articles

Is cancer a death sentence for Indigenous Australians? The impact of culture on cancer outcomes

Aim: Indigenous Australian cancer patients have poorer outcomes than non-Indigenous cancer patients after adjusting for age, stage at diagnosis and cancer type. This is not exclusive to the Indigenous population of Australia. The aim of this review is to explore the reasons why Indigenous Australians face a higher cancer mortality rate when compared to their non-Indigenous counterparts. Methods: A literature search was conducted using PubMed and Medline to identify articles with quantitative research on the differing survival rates and cancer epidemiology, and qualitative data on postulated reasons for this discrepancy. Qualitative studies, non-systematic topic reviews, quality improvement projects and opinion pieces were also reviewed in this process, with the belief that they may hold key sources of Indigenous perspectives, but are undervalued in the scientific literature. Results: Although allcause cancer incidence is lower within Indigenous Australians, the probability of death was approximately 1.9 times higher than in non-Indigenous patients. Occurrence of cancer types differ slightly among the Indigenous population, with a higher incidence of smoking-related cancers such as oropharyngeal and lung cancers, and cancer amenable to screening such as cervical cancer. Indigenous patients generally have a later stage at diagnosis, and are less likely to receive curative treatment. This discrepancy has been attributed to health service delivery issues, low uptake of screening, preventative behaviours, communication barriers, socioeconomic status and non-biomedical beliefs about cancer. Conclusion: The implication of these findings on the future of Indigenous cancer care indicates the fundamental social, cultural and serviced-based change required for long-term sustainable improvement in reducing Indigenous mortality rates. To ‘close the gap’ we need to make further collaborative system changes based on Indigenous cultural preferences.

Introduction

Indigenous Australian cancer patients have much poorer outcomes than non-Indigenous cancer patients after adjusting for age, stage at diagnosis and cancer type. [1] Statistics from 2005 show that cancer was the third highest cause of death in Indigenous people, as for all Australians, causing 17% and 30% of all deaths respectively. [1,3] However after adjusting for age and sex, Indigenous people had a 50% higher cancer death rate. [4] Indigenous Australians have a higher incidence of rapidly-fatal cancers that are amenable to screening or are preventable, particularly lung and other smoking related cancers. [2] One of the major contributors to increased mortality is the advanced stage at cancer diagnosis. In addition to this, Indigenous people are less likely to receive adequate treatment. The aim of this review is to explore the reasons why Indigenous Australians face a higher cancer mortality rate when compared to their non-Indigenous counterparts. This review will display the epidemiology of cancer types and discuss the grounds for this discrepancy, including a focus on the causes for advanced stage at diagnosis, geographical distribution of the population, socioeconomic status, service delivery and cultural beliefs about cancer.

A literature search was conducted using PubMed and Medline to identify articles with quantitative research on the differing survival rates and cancer epidemiology, and qualitative data on postulated reasons for this discrepancy. Qualitative studies, non-systematic topic reviews, quality improvement projects and opinion pieces were also reviewed in this process, with the belief that they may hold key sources of Indigenous perspectives, but are undervalued in the scientific literature. Combinations of key words such as ‘Indigenous’, ‘cancer’, ‘incidence’, ‘mortality’, ‘non-Indigenous’, and ‘cultural beliefs’ were used, in addition to criteria limiting articles to those published after 2000 and within Australia, although some key international references were included.

Generally, Indigenous Australians have a life expectancy seventeen years younger than their non-Indigenous counterparts, and a burden of chronic disease 2.5 times higher. [5] This is not exclusive to the Indigenous population of Australia; similar findings have been shown for Indigenous people of Canada, New Zealand and the United States. [6,7,8] The Aboriginal and Torres Strait Islander people of Australia, who account for 2.4% of the total population, will be referred to as Indigenous people for the purpose of this review, [9] although their separate cultural entities are recognised.

Epidemiology

Indigenous people in the Northern Territory diagnosed with cancer between 1991 and 2000 were 1.9 times more likely to die than other Australians, after adjusting for cancer site, age and sex (Figure 1). [10] The prevalence of cancer types differed among the Indigenous population, with a higher incidence of, and mortality from, smokingrelated cancers such as oropharyngeal and lung cancers, and cancers amenable to screening, such as cervical and bowel cancer. [10,11] In addition, studies from New South Wales, the Northern Territory and Queensland have found that Indigenous people are more likely to have advanced disease at diagnosis for all cancers combined. [2,12,13] Notably, lung cancer is diagnosed earlier in Indigenous people; this is thought to be due to the high prevalence of lung conditions such as tuberculosis and chronic lung disease among the Indigenous population. [2] Statistics show that only 11% of Indigenous bowel cancer patients in the Northern Territory, compared to 32% of non- Indigenous patients, had an early diagnosis. This has potential for improvement through the use of faecal occult blood programs as a cost effective screening tool. [6] In addition to the late stage at diagnosis, the low rate of cancer survival in Indigenous patients can be, in part, attributed to the prevalence of high fatality cancers, treatmentlimi ting comorbidities and high uptake of palliative or non-aggressive treatment options. [2]

Studies from across a number of states in Australia have shown that Indigenous patients are less likely to undergo treatment. In a study reported by Hall et al. in Western Australia, 26 (9.5%) of 274 Indigenous lung cancer patients underwent surgery, as compared to 1693 (12.9%) of 13,103 non-Indigenous lung cancer patients, from 1982 to 2001. [16] In the same time period, one (1.5%) of 64 Indigenous prostate cancer patients, versus 1,787 (12.7%) of 12,123 non-Indigenous prostate cancer patients underwent surgery. The study concluded that the Indigenous population with prostate or lung cancer were less likely to undergo surgery than their non-Indigenous counterparts. [14] A Queensland study by Valery et al. also reported that Indigenous cancer patients were less likely to undergo surgical treatment. [9] This may partly be explained by advanced stage at diagnosis; however, the results are statistically significant, demonstrating under-treatment after this adjustment. Treatment choice and barriers to care were identified as important contributors to this discrepancy. [14]

Longitudinal trends from 1995 to 2005 in the Northern Territory reported a downward trend in all cancer incidence among the non- Indigenous people, as opposed to an increase in Indigenous people. The all-cancer mortality declined significantly within non-Indigenous people, while there was little change in the death rate of Indigenous people. [10] Nation-wide trends between 1982 and 2007 show that the incidence of all cancers combined increased from 383 cases per 100,000 to 485 per 100,000. [15]

Rural and Remote Locations

Lower survival rates were observed in Queensland, Western Australia and the Northern Territory in Indigenous cancer patients from remote communities. [4,16] Indigenous people are ten times more likely to live in remote areas of Australia than non-Indigenous people. [17] This has implications for service delivery of screening, diagnosis and treatment, as well as access to preventative health education. In rural and remote Australia there is a shortage of healthcare providers and adequate primary health care facilities to cater for the vast geographical distances. There is a difficulty in ensuring transport links between major centres for patients requiring referral. These factors probably contribute to the outcomes.

Socioeconomic Status

Like other Indigenous populations, Indigenous Australians are overrepresented in the low socioeconomic strata. [1,2] Since the colonisation of Australia by the non-Indigenous population, the Indigenous people have progressively lost their cultural expression and practices, resulting in disempowerment. [8] Subsequent ‘welfare dependency’ with continuing loss of skills, unemployment and hopelessness have been suggested as contributory factors. [12] There are a multitude of reasons as to why disempowerment has manifest in poor levels of education, employment and health outcomes, which is beyond the scope of this discussion. In addition, Indigenous Australians are more likely, in varying degrees, to be exposed to poor environmental health such as disadvantaged living conditions. This includes overcrowding, poor nutrition and obesity, tobacco, excessive alcohol consumption and other drugs, and higher rates of human papillomavirus (HPV) infection, which are linked to the aetiology of cervical and head and neck cancers. [1,11,17] Behavioural risk factors linked to low socioeconomic status may contribute to higher levels of comorbidities.

Culture

Cultural isolation, power imbalances and differing health beliefs of cancer causation are patient factors that also contribute to poorer prognosis. Indigenous people are sensitive to power imbalances in their interaction with healthcare providers. [12] Psychological stress, common to many vulnerable populations, has been consistently associated with sub-optimal health outcomes for Indigenous people and an important obstacle in accessing healthcare. Peiris et al. believes that ‘cultural safety’ within healthcare facilities is paramount in addressing this problem. [12] Creating open-door policies, welcoming waiting rooms and reception staff who know the community are means of reorientating the health services and preventing the cultural disconnect. [12] However, there is a lack of community-controlled health services in many areas, and a relative lack of skilled Indigenous people in the workforce. Improving these factors would greatly enhance the cultural safety and community-specific delivery of health. [4,12] Studies comparing the Maori and Pacific Islander people in New Zealand have extrapolated on similar causes of ethnic inequalities in access to culturally acceptable health services. [6,7,8]

Language

In 2002, 66% of Indigenous Australians in the Northern Territory reported speaking a language other than English at home; in Western Australia, South Australia and Queensland the number of Indigenous language speakers was eleven to fourteen percent. [18] A study by Condon et al. reported that cancer survival was strongly associated with the patient’s first language. [2] After adjusting for treatment, cancer stage and site, it was shown that the risk of death for Indigenous native language speakers was almost double that of Indigenous English speaking and non-Indigenous patients. [2] It is postulated that communication difficulties, social and cultural ‘disconnect’ from mainstream health services and poor health literacy may be linked to native first language. [9] This valuable finding reinforces the importance of using Aboriginal Health Workers and translators in clinical practice.

Beliefs about Cancer

Attitudes to cancer and medical services strongly influence the use of diagnostic or curative care. Shahid et al. interviewed Indigenous people from various geographical areas in Western Australia about their beliefs and attitudes towards cancer. [3] The findings were surprising. Many Indigenous people believe cancer is contagious, and attributed cancer to spiritual curses, bad spirits or as punishment from a past misdeed. It was found that blaming others or one’s own wrongdoing as a cause of cancer or illness is widespread within Aboriginal communities, where spiritual beliefs about one’s wellbeing predominate. [3] Shahid et al. claimed that attribution of cancer to spiritual origins lead to acceptance of disease without seeking healthcare. [3] In addition, the Indigenous cancer sufferer may feel ashamed of their ‘wrongdoings’ and hide their symptoms, delaying diagnosis. [3]

Fatalistic attitudes towards cancer diagnosis in the general Australian population has changed in recent times, with the dissemination of information regarding curative cancer treatments, and the shifting focus toward understanding the biological basis of cancer and educating the public about screening and preventative behaviours such as the bowel cancer screening and the HPV vaccination. However, the low socioeconomic status and poor educational background of many Indigenous Australians has limited their access to such information. [3] In many Indigenous communities the fatalistic expectations of a cancer diagnosis remain. Such fatalistic beliefs are associated with delays in cervical cancer screening, late presentation of cancer symptoms, and patients who are lost to follow-up, contributed to by the aforementioned beliefs. For example, some Indigenous women with cervical cancer in Queensland blamed cancer on the loss of a traditional lifestyle. [19] Other beliefs about cancer are that screening protects from cancer and that cancer is contagious. Studies from New Zealand, Canada and the US have shown similar themes concerning non-biomedical Indigenous beliefs about cancer. [6]

In addition to the view that “cancer means death” were views of overreliance or mistrust in doctors. Often personal stories of an individual’s unmet expectations of the medical system spread within the community and influenced other’s attitudes; examples include patients who had fi nished treatment, thought they had been cured of cancer, and were then lost to follow-up, or the idea that screening prevents cancer. [20] Traditional healing still has a role in many Indigenous communities for health and wellbeing, as well as the importance during palliation of the cancer patients, often as a link to their connection with their country and ancestral roots. [3]

Recommendations

Culturally-appropriate service delivery

Diagnosing cancers earlier in the Indigenous population would increase the chance for curative treatment and reduction in overall mortality. Increasing primary health care services and their culturally appropriate delivery would address this need. However, improving the access to and use of relevant services for Indigenous people currently remains a challenge. For women’s issues, there may be stigma, shame and embarrassment associated with sexually transmitted infections and cervical cancer, as well as the cultural factors associated with denial of symptoms and gender roles of healthcare workers. [20] Service delivery failures are related to inadequate or inappropriate recallsystems, privacy during screening, especially in small communities, sex of the healthcare provider, timing and location of screening, discontinuity of care, difficulty maintaining cold chain and promoting vaccinations such as GardasilTM. [17] National data for breast and cervical cancer screening reveals that Indigenous women participate at about two-thirds of the national rate. However, the implementation of the culturally acceptable “Well Women’s Screening Program” in the Northern Territory, substantially improved Indigenous participation in PAP test screening from 33.9% in 1998 to 44% in 2000. [19] Similar initiatives have also been successfully implemented in Queensland. [22] This highlights the efficacy of culturally appropriate services tailored to the population.

Education

Programs to decrease tobacco use and to improve other behavioural risk factors need to be designed appropriately for use in the settng of communication difficulty and poor health literacy, and they need to address the cultural role of smoking in Indigenous people. [1] In addition, health service delivery improvements such as health education, promotion, screening programs and cultural safety, such as those demonstrated in the successful “Well Women’s Screening Program”, [19] will also contribute to a successful intervention.

Conclusion

Australian national ‘Closing The Gap’ targets include “to halve the life expectancy gap [between Indigenous and non-Indigenous Australians] within a generation.” [5] Language, cultural barriers, geographical distance, low socioeconomic status, high-risk health behaviours and traditional and non-biomedical beliefs about cancer are all reasons why Indigenous Australians have worse cancer outcomes than non- Indigenous Australians. The implication of these findings on the future of Indigenous cancer care and on meeting the national targets signifies the fundamental social, cultural and service-based changes required for long-term sustainable improvement in reducing the Indigenous mortality rates. The underlying cultural beliefs and individual perceptions about cancer must be specifically addressed to develop effective screening and treatment approaches. Educational material must be designed to better engage Indigenous people. In addition, Aboriginal cancer support services and opportunities for Aboriginal cancer survivors to be advocates within their communities may increase Indigenous peoples’ willingness to accept modern oncology treatments. Through these improvements, a tailored approach to Indigenous cancer patients can meet the spiritual, cultural and physical needs that are imperative for a holistic approach in their management.

Conflicts of interest

None declared.

Correspondence

S Koefler: sophia.koefler@gmail.com

References

[1] Cunningham J, Rumbold A, Zhang X, Condon J. Incidence, aetiology and outcomes of cancer in Indigenous people of Australia. Lancet Oncology. 2008;8:585-95.

[2] Condon J, Barnes T, Armstrong B, Selva-Nayagam S, Elwood M. Stage at diagnosis and cancer survival for Indigenous Australians in the Northern Territory. Med J Aust. 2004;182(6):277-80.

[3] Shahid S, Finn L, Bessarab D, Thompson S. Understanding, beliefs and perspectives of Aboriginal people in Western Australia about cancer and its impact on access to cancer services. BMC Health Services Research. 2009;9:132-41.

[4] Roder D, Currow D. Cancer in Aboriginal and Torres Strait Islander people of Australia. Asian Pacific J Cancer Prev. 2008;9(10):729-33.

[5] Anderson I. Closing the indigenous health gap. Aust Fam Physician. 2008;37(12):982.

[6] Shahid S, Thompson S. An overview of cancer and beliefs about the disease in Indigenous people of Australia, New Zealand and the US. Aust NZ J Public Health. 2009;33:109-18.

[7] Paradies Y, Cunningham J. Placing Aboriginal and Torres Strait Islander mortality in an international context. Aust NZ J Public Health. 2002;26(1):11-6.

[8] Jeff reys M, Stevanovic V, Tobias M, Lewis C, Ellison-Loschmann L, Pearce N et al. Ethnic inequalities in cancer survival in New Zealand: linkage study. Am J Public Health. 2005;95(5):834-7.

[9] Valery P, Coory M, Stirling J, Green A. Cancer diagnosis, treatment, and survival in Indigenous and non-Indigenous Australians: a matched cohort study. The Lancet. 2006;367:1842-8.

[10] Zhang X, Condon J, Dempsey K, Garling L. Cancer incidence and mortality in Northern Territory, 1991-2005. Department of Health and Families; Darwin 2006:1-65.

[11] Condon J, Barnes T, Cunningham J, Armstrong B. Long-term trends in cancer mortality for Indigenous Australians in the Northern Territory. Med J Aust. 2004;180:504-407.

[12] Peiris D, Brown A, Cass A. Addressing inequities in access to quality health care for indigenous people. Canadian Med Ass J. 2008;179(10): 985-6.

[13] Supramaniam R, Grindley H, Pulver LJ. Cancer mortality in Aboriginal people in New South Wales, Australia, 1994-2001. Aust NZ J Public Health. 2006;30(5):453-6.

[14] Hall S, Bulsara C, Bulsara M, Leahy T, Culbong M, Hendrie D et al. Treatment patterns for cancer in Western Australia, does being Indigenous make a difference? Med J Aust. 2004; 181(4): 191-4.

[15] Australian Institute of Health and Welfare & Australasian Association of Cancer Registries 2010. Cancer in Australia: an overview. AIHW. 2010;60(10):14-5.

[16] Hall S, Holman C, Sheiner H. The influence of socio-economic and locational disadvantage on patterns of surgical care for lung cancer in Western Australia 1982-2001. Aust Health Rev. 2004;27(2):68-79.

[17] Jong K, Smith D, Yu X, O’Connell D, Goldstein D, Armstrong B. Remoteness of residence and survival from cancer in New South Wales. Med J Aust. 2004;180:618-21.

[18] Condon J, Cunningham J, Barnes T, Armstrong B, Selva-Nayagam S. Cancer diagnosis

and treatment in the Northern Territory: assessing health service performance for

Indigenous Australians. Intern Med J. 2006;36:498-505.

[19] Binns P, Condon J. Participation in cervical screening by Indigenous women in the Northern Territory: a longitudinal study. Med J Aust. 2006;185(9):490-4.

[20] Lykins E, Graue L, Brechting E, Roach A, CochettC, Andrykowski M. Beliefs about cancer causation and prevention as a function of personal and family history of cancer: a national, population-based study. Psycho-oncology. 2008;17:967-74.

[21] Henry B, Houston S, Mooney G. Institutional racism in Australian healthcare: a plea for decency. Med J Aust. 2004;180:517-9.

[22] Augus S. Queensland Aboriginal and Torres Strait Islander women’s cervical screening strategy. Population Health Branch Queensland Health 2010. 10-27.

Categories
Review Articles

Human papillomavirus in head and neck squamous cell carcinoma

Background: Head and neck squamous cell carcinoma (HNSCC) is a significant global health burden. Approximately 25 percent of HNSCC cases are caused by human papillomavirus (HPV). These particular cancers of viral aetiology have been found to have distinct characteristics in regards to presentation, treatment and prognosis. Current advances in vaccinology have the capability to drastically decrease the incidence of HPV-positive HNSCC. Methods: A literature review was undertaken through MEDLINE/PubMED/Ovid databases. The terms “HPV,” “HNSCC,” “carcinogenesis,” “treatment,” “prognosis” and “vaccine” were searched. Only studies published in English were considered with 65 articles selected and analysed. Preference was given to studies published in the last ten years. Results: The incidence of HPV-positive HNSCC is increasing. Infection with HPV can result in cancer through the expression of oncogenic proteins which disrupt normal cellular turnover. Aggressive treatment is often undertaken causing significant morbidity in many patients. A proportion of patients die from this disease, suggesting that these cancers have a considerable impact on society. Conclusion: Human papillomavirus is an infectious agent that is likely transmitted through skin-to-skin contact. The virus integrates into the DNA of the host with the high oncogenic risk genotypes, HPV 16 and 18 being strongly linked to HPV-positive HNSCC development. Prevention through vaccination against these genotypes is currently an option for all individuals. The cervical cancer vaccines immunise non-exposed females against HPV 16 and 18. Vaccination of both males and females will prevent HPV-positive HNSCC.

Categories
Review Articles

Early impact of rotavirus vaccination

Background: Rotavirus is the most common cause of severe gastroenteritis in children and two vaccines to prevent rotavirus infection have been licensed since 2006. The World Health Organisation recommends the inclusion of rotavirus vaccination of infants in all national immunisation programs. Aim: To review current literature evaluating the global impact of rotavirus immunisation programs over the first two years of their implementation. Methods: A MEDLINE search was undertaken to identify relevant observational studies. Results: Eighteen relevant studies were identified which had been carried out in eight countries. Introduction of the vaccine was associated with a reduction in all-cause gastroenteritis hospitalisation rates of 12- 78% in the target group and up to 43% in older groups ineligible for the vaccine. Hospitalisation rates for confirmed rotavirus cases ranged between 46-87% in the target group. Mortality from all-cause gastroenteritis was reduced by 41% and 45% in two countries studied. Conclusions: Early research evaluating rotavirus immunisation programs suggests significant decreases in diarrhoeal disease rates extending beyond the immunised group. Further monitoring will allow vaccine performance to be optimised and for the long-term effect of vaccination programs to be assessed.

Categories
Review Articles

Prevention of rheumatic heart disease: Potential for change

Rheumatic heart disease (RHD), an autoimmune reaction to an infection of rheumatogenic group A streptococcus bacteria, is characterised primarily by progressive and permanent heart valvular lesions, although other parts of the heart may be affected. Despite an overall decrease in the incidence of RHD in developed countries, it remains a pertinent health issue with high rates in developing countries and amongst certain Indigenous populations in industrialised countries. Primary, secondary and tertiary strategies for the prevention of rheumatic heart disease exist, as do numerous barriers to such strategies. A review of the literature, incorporating its epidemiology and pathophysiology, demonstrates that interventions at various stages of the disease may reduce the collective burden of disease.

Categories
Feature Articles

Should artificial resuscitation be offered to extremely premature neonates?

Introduction

‘Change’ is scientific, ‘progress’ is ethical; change is indubitable, whereas progress is a matter of controversy.” – Bertrand Russell

Forty years ago it was generally accepted that a baby born more than two months premature could not survive. Now neonates as young as 22 weeks can be kept alive with medical intervention. This essay will explore the medical, social and legal aspects of artificial resuscitation of extremely premature neonates and argue for a change to a palliative approach towards infants born at the threshold of viability.

Background

Extremely premature newborns face a number of medical problems, affecting almost all systems of the body. These problems include extreme skin immaturity and fluid balance instability, lung immaturity and breathing problems, malnutrition and gut damage, retinopathy of prematurity, early and late onset infections and brain damage which can lead to a spectrum of long-term neurological sequelae. [1,2]…

Categories
Review Articles

Stethoscopes as vectors of infections

Aim: To conduct a review of the literature to evaluate whether stethoscopes constitute a clinically significant vector of healthcareassociated infection, and to explore the behaviour, attitudes and beliefs about stethoscope hygiene amongst medical students. Methods: Section one: PubMed was searched for empirical studies written in English, published before 1 May 2010, dealing with colonisation rates of stethoscopes and self-reported frequency of stethoscope cleaning by healthcare staff. Thirty-one articles were systematically reviewed. Section two: Qualitative and quantitative cross-sectional study of medical students. A convenience sample of seventeen undergraduate medical students in years two, three and four were asked a series of thirteen questions exploring their knowledge, practice of and attitudes towards stethoscope hygiene. Results: The diaphragm and bell of stethoscopes are colonised with micro-organisms on average 87.3% of the time. On average, 14% of stethoscopes carry MRSA, and 16.5% carry gram-negative species. On average, 58.8% of doctors clean their stethoscope annually or never. Fifty-nine percent of students surveyed had never cleaned their stethoscope. Only 29% of students had ever been advised about stethoscope hygiene. Eighty-two percent of students felt senior colleagues had influenced their attitude (positive or negative) toward stethoscope hygiene. Conclusions: Stethoscopes potentially represent a moderate-to-high risk of infection transmission, particularly in vulnerable settings, yet stethoscope hygiene is rarely considered or practiced by doctors and medical students. Improving stethoscope hygiene in practice requires addressing the lack of formal education on the subject and the shortage of positive role models.

Categories
Review Articles

Preventing vertical hepatitis B transmission across all borders: A review of current concepts

Aim: The aim of this review is to emphasise the global significance of Hepatitis B (HBV) and its vertical transmission, and to summarise the current status of preventative strategies. Methods: A literature review was carried out. PubMed, The Cochrane Collaboration and Medline were searched for both primary studies and reviews pertaining to vertical HBV transmission, its prevention and barriers to prevention. Key words used included “HBV,” “Hepatitis B,” “vertical transmission,” “mother to child transmission,” “prevention” and “epidemiology.” Results: HBV is a major cause of death from liver cancer and liver failure. HBV is the ninth leading cause of death internationally and accounts for up to 80% of the world’s primary liver cancers. In highly endemic areas, 75% of chronic HBV is acquired by vertical transmission (mother to child transmission at birth), or by horizontal transmission in early childhood. The earlier in life the disease is acquired, the greater the adverse consequences. Available therapies for preventing mother to child transmission are very effective and include multiple doses of HBV vaccine and usually, HBV immunoglobulin. However, up to 10% of infants acquire HBV despite this standard prophylaxis. Whether anti-viral agents should be given to mothers with a high viral load to prevent transmission remains controversial. Conclusion: HBV is an extremely important global public health issue. Prevention of vertical transmission is the most important preventative strategy and current prophylactic therapies are highly effective. Emerging approaches for mothers with a high viral load require further investigation to determine whether they are effective and safe. Developing countries face the issues of cost, access and education to apply prevention strategies, while developed countries need processes to ensure adherence to established recommendations.

Categories
Feature Articles

Better preparing Australian medical graduates: Learning from the New Zealand model of trainee interns

The New Zealand experience of preparation

In New Zealand, the trainee intern (TI) year is a clinical apprenticeship year undertaken in a hospital under the aegis of a medical school. It is undertaken in the final year of medical school and comprises eight clinical attachments (Table 1). The year aims to provide learning in the work environment with limited clinical responsibility. Trainee interns are paid an annual stipend (60% of a house officer’s salary) from the New Zealand government via the education budget; however, the year remains under the jurisdiction of the medical school and thus retains an education focus. Although required to be supervised, TIs contribute to service (taking on approximately one-third of the patient load) and often stay on after graduation in their respective hospitals for postgraduate year one (PGY1). [1,2] Formal education and rotation assessment occur continuously throughout the year.

In Australia, there is no equivalent transition from medical school to internship and this transition may be overlooked. Medical graduates switch from enjoying little or no clinical responsibility to suddenly being accountable for the safety and management of a large number of inpatients. This precipitous change of role affords minimal time for satisfactory adaptation and preparation for the stress associated with internship. Some medical schools have attempted to soften this transition by introducing pre-internship terms into the curricula. [3]

Transitional stress from medical student to intern

The transition from university to workplace, with accompanying increase in professional responsibilities, is inherently challenging for most graduates. The reality of being personally responsible for patients can induce stress, psychiatric morbidity (including depression and anxiety) and burnout. [4] In a prospective longitudinal study of 110 interns who had graduated from the University of Sydney, 70% of interns met criteria for a psychiatric disturbance on at least one occasion during PGY1. This level of stress leads to decreased effectiveness at work and a reduced level of patient care. [4,5]

Some identified stressors include newly gained responsibility, managing uncertainty, working in multi-professional teams, experiencing the sudden death of patients and feeling unsupported. The stress of transition can be reduced with early clinical exposure, including opportunities to act in the role of a junior doctor. [6]

Lack of preparedness for internship

Despite extensive research and frequent appraisal of medical curricula, junior doctors still perceive gaps in their preparation for internship. In one survey of interns, medico-legal aspects and resuscitation skills were identified as areas where…

Categories
Case Reports

Enforcing medical treatment under the Involuntary Treatment Order: An ethical dilemma?

Introduction: This case report aims to address the ethical issues and obligations of enforcing medical care onto psychiatric patients under the Queensland Mental Health Act 2000 Involuntary Treatment Order (ITO), and will also present Queensland’s legal standpoint and limitations on providing this care under the Act. Case Presentation: PF, a 47 year old male with a history of depression and recent diagnosis of Gleason 7 prostate cancer was admitted to the acute mental health unit following an intentional overdose of alprazolam. His risk to himself prompted the application of an ITO. Although PF was due for investigation of his recently diagnosed prostate cancer, he refused following his suicide attempt. Conclusion: Although an ITO allows for enforcement of psychiatric treatment, no legal allowances exist for enforcement of medical care. In situations where medical conditions may be indirectly detrimental to a person’s mental health, ethicallyappropriate techniques should be employed.

Categories
Case Reports

Ovarian hyperstimulation syndrome

This case report describes a lady who presented with abdominal pain, hypotension and multiple ovarian follicles following egg collection and embryo transfer. She was provisionally diagnosed with Ovarian Hyperstimulation Syndrome (OHSS) and managed accordingly. This case study describes her clinical presentation, investigations, progress, management and outcome. No current laboratory diagnostic/prognostic markers are available for OHSS; the condition is currently diagnosed clinically. The subsequent discussion elaborates on the epidemiology, pathophysiology, clinical features, assessment, management and risk factors of OHSS, and aims to increase awareness of this important complication of infertility treatment to assist diagnosis, prevention and early institution of treatment.